T. Rowe Price Associates’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,885,112
| Closed | -$28.4M | – | 3020 |
|
|
2022
Q3 | $28.4M | Sell |
1,885,112
-35,198
| -2% | -$530K | ﹤0.01% | 799 |
|
|
2022
Q2 | $25.7M | Sell |
1,920,310
-251,925
| -12% | -$3.37M | ﹤0.01% | 1100 |
|
|
2022
Q1 | $41.9M | Sell |
2,172,235
-69,682
| -3% | -$1.34M | ﹤0.01% | 1031 |
|
|
2021
Q4 | $51.4M | Buy |
2,241,917
+38,313
| +2% | +$878K | ﹤0.01% | 994 |
|
|
2021
Q3 | $42.7M | Buy |
+2,203,604
| New | +$42.7M | ﹤0.01% | 1076 |
|